Walleye Trading LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$51.3 - $64.42 $92,340 - $115,956	1,800 New	1,800 $102,000
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $26,656 - $33,680	800 New	800 $29,000
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $111,724 - $189,380	3,400 Added 161.9%	5,500 $210,000
Q4 2022 Feb 14, 2023	BUY	$40.06 - $59.44 $40,060 - $59,440	1,000 Added 90.91%	2,100 $119,000
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $3,853 - $5,178	100 Added 10.0%	1,100 $43,000
Q2 2022 Aug 08, 2022	SELL	$37.35 - $48.3 $85,905 - $111,090	-2,300 Reduced 69.7%	1,000 $44,000
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $51,152 - $65,696	-1,600 Reduced 32.65%	3,300 $132,000
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $1.79 Million - $2.29 Million	-56,200 Reduced 91.98%	4,900 $197,000
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $2.35 Million - $2.84 Million	61,100 New	61,100 $2.49 Million
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $683,584 - $903,056	-17,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $482,022 - $627,690	-12,200 Reduced 40.94%	17,600 $734,000
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $869,797 - $1.47 Million	-33,700 Reduced 53.07%	29,800 $1.27 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $319,176 - $367,412	-12,400 Reduced 16.34%	63,500 $1.67 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $533,000 - $879,368	32,800 Added 76.1%	75,900 $2.04 Million
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $59,770 - $93,868	-4,300 Reduced 9.07%	43,100 $775,000
Q4 2019 Feb 14, 2020	BUY	$14.93 - $19.53 $259,782 - $339,822	17,400 Added 58.0%	47,400 $840,000
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $443,840 - $516,548	29,200 Added 3650.0%	30,000 $465,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $11,800 - $13,808	800 New	800 $14,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$831 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$608 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$313 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$192 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$161 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account